Departments | |
---|---|
Book Series (78) |
1075
|
Medien- und Kommunikationswissenschaften |
4
|
Humanities |
1997
|
Natural Sciences |
5105
|
Mathematics | 214 |
Informatics | 290 |
Physics | 950 |
Chemistry | 1289 |
Geosciences | 124 |
Human medicine | 223 |
Stomatology | 9 |
Veterinary medicine | 81 |
Pharmacy | 140 |
Biology | 788 |
Biochemistry, molecular biology, gene technology | 107 |
Biophysics | 22 |
Domestic and nutritional science | 40 |
Agricultural science | 965 |
Forest science | 197 |
Horticultural science | 15 |
Environmental research, ecology and landscape conservation | 130 |
Engineering |
1552
|
Common |
80
|
Leitlinien Unfallchirurgie
5. Auflage bestellen |
Table of Contents, PDF (57 KB)
Extract, PDF (210 KB)
ISBN-13 (Hard Copy) | 9783954049608 |
ISBN-13 (eBook) | 9783736949607 |
Language | English |
Page Number | 128 |
Lamination of Cover | matt |
Edition | 1. Aufl. |
Book Series | Hochschulschriften - Institut für Systembiotechnologie, Universität des Saarlandes |
Volume | 4 |
Publication Place | Göttingen |
Publication Date | 2015-07-13 |
General Categorization | Dissertation |
Departments |
Microbiology and biotechnology
|
Keywords | violacein, deoxyviolacein, Escherichia coli, metabolic engineering |
Violacein and deoxyviolacein are promising therapeutics against pathogenic bacteria and viruses as well as tumor cells. In the present work, systems-wide metabolic engineering was applied to Escherichia coli for heterologous production of these high-value products. First, a high performance liquid chromatography method for accurate separation and quantification of violacein and deoxyviolacein was developed. Afterwards, a basic producer, E. coli dVio-1, that expressed the vioABCE cluster from Chromobacterium violaceum under control of the araBAD promoter and induction by L-arabinose, was constructed. Targeted intracellular metabolite analysis then identified bottlenecks in pathways that supply tryptophan, the major product building block of the natural products of interest. This was used for systems-wide engineering of serine, chorismate and tryptophan biosynthesis and the non-oxidative pentose-phosphate pathway, followed by elimination of L-arabinose catabolism. Transferred to a glycerol-based fed-batch process, E. coli dVio-8 surpassed the gram scale and produced 1.6 g L-1 deoxyviolacein (> 99.5% purity). The created chassis of a high-flux tryptophan pathway was complemented by genomic integration of the vioD gene of Janthinobacterium lividum, which enabled exclusive production of violacein (710 mg L-1 with 99.8% purity). This demonstrates the potential of E. coli as a platform for production of tryptophan based therapeutics.